A new guideline from Kidney Disease: Improving Global Outcomes (KDIGO) updates recommendations on the management of antineutrophilic cytoplasmic antibody (ANCA)–associated vasculitis (AAV) to address ...
As stated by the authors, treatment for systemic vasculitis should be considered only if the diagnosis—made on the basis of clinical and histopathological findings—is certain, or if compelling ...